Insurance Barriers Limit Pulmonary Rehab Access
Insurance coverage is a significant barrier to accessing virtual pulmonary rehabilitation programs for people with COPD.
Insurance coverage is a significant barrier to accessing virtual pulmonary rehabilitation programs for people with COPD.
The FDA approved Moderna's mFlusiva, the first seasonal influenza vaccine using mRNA technology to enter the US market.
For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.
Masimo received FDA 510(k) clearance for the Patient State Index (PSi) , a new monitoring index that helps clinicians track brain activity and sedation levels in children during surgery and intensive care.
In kidney transplant recipients, early antiviral treatment with remdesivir reduced the risk of organ rejection and heart complications by nearly half for up to one year after diagnosis.
Wearable stickers can accurately measure sweat chloride levels in cystic fibrosis patients in under an hour without specialized laboratory equipment.
A closer look at suction and airway secretion clearance therapy devices from ABM, Baxter, Neotech, Sentec, Seoil Pacific, and Synchrony Medical.